蓝丰生化：控股子公司增资扩股 公司持股比例降至75.19%

Core Viewpoint - The announcement indicates that Jiangsu Lanfeng Biochemical Co., Ltd., a subsidiary of Lanfeng Biochemical, will receive a capital increase of 30 million yuan from one of its original shareholders, Yuanjiang Bide Chemical Co., Ltd. [1] Group 1 - The capital increase consists of 3 million yuan added to registered capital and 27 million yuan added to capital reserves [1] - Other original shareholders of Lanfeng Biochemical plan to waive their preemptive rights to the capital increase [1] - After the capital increase, the registered capital of Lanfeng Biochemical will rise from 130 million yuan to 133 million yuan, and the company's ownership stake in Lanfeng Biochemical will decrease from 76.92% to 75.19% [1]